Financial News
All News about Novo Nordisk A/S ADR
![](https://www.investors.com/wp-content/uploads/2020/04/Stock-bullfightingbear-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/753496/growth-graph.jpg)
![](https://g.foolcdn.com/editorial/images/753454/ozempic.jpg)
![](https://g.foolcdn.com/editorial/images/753016/stock-certificate-investment-retire-heirloom-donate-capital-gains-tax-getty.jpg)
1 Stock-Split Stock to Buy Hand Over Fist in November, and 1 to Avoid
November 03, 2023
Via The Motley Fool
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
Novo Nordisk (NVO) Q3 2023 Earnings Call Transcript
November 02, 2023
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/images/story/2023/11/02/wegovy-company.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/09/stock-NovoNordisk-02-shutter.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Novo Nordisk
November 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Novo Nordisk Unusual Options Activity For October 30
October 30, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Looking At Novo Nordisk's Recent Unusual Options Activity
October 26, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/ww_international_shutter2_0.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/tech1600d.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/artificial_chart_shutter_2.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/08/Stock-McKesson-03-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/01/restaurant_eating_unsplash.jpg?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/med_20231031170121_investor-patience-tested-as-pharmaceutical-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/31/opzemic.shutterstock_2172980959.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/752405/scientist-looks-at-test-tube.jpg)
Can Diabetes, Weight-Loss Drugs Get Even Better?
October 30, 2023
![](https://g.foolcdn.com/editorial/images/752402/two-investors-meet-and-discuss.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/27/bulls_bears6.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/27/weightloss.shutterstock_2270507665.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2023/10/TECH1_ozempic_102723_newscom.jpg)
![](https://investorplace.com/wp-content/uploads/2023/07/businessman-mountain-growth-stocks-flag-peak-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/27/ozempic.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.